Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Solgar: The Leonia, N.J.-based firm previewed multiple new products at the Natural Products Association's Natural Marketplace in Las Vegas July 20-22 including four new SKUs in a dairy-, lactose- and milk-free probiotic supplements line. The new Advanced Acidophilus products contain between 500 mil. and 5 bil. micro-organisms per use, according to the firm. The products retail in 50- to 250-count bottles priced at $7.70 to $28.10. Another new product debuting at the show is a 50-count bottle of 100 mcg vitamin K2 product carrying an SRP of $24.90. One function of K2 is it plays an "important role in forming blood clotting proteins in the liver," Solgar says. The company also launched PC-Extend, which contains 200 mg of polygonum cuspidatum, which supplies 100 mg of reseveratrol "to support healthy biomarkers and improve quality of life" and costs $24.80 for a 60-count bottle. The company also introduced AC-11, a proprietary, patented and water soluble vegetable extract of uncaria tomentosa "for enhanced DNA protection and repair" in 60-count bottles for $34.50. Lastly, Solgar introduced a 500 mg achiote leaf product used "to strengthen immune resistance" in 60-count bottles for $28.00...

You may also be interested in...

Osteoporosis Foundation Discusses Evidence To Increase Vitamin D RDA

The National Osteoporosis Foundation joins other research groups calling for an increase to the recommended daily allowance of vitamin D

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts